Dramatic Reduction in Infective Endocarditis–Related Mortality With a Management-Based Approach
about
Role of radionuclide imaging for diagnosis of device and prosthetic valve infectionsVancomycin treatment of infective endocarditis is linked with recently acquired obesity.Histoplasma capsulatum prosthetic valve endocarditis with negative fungal blood cultures and negative histoplasma antigen assay in an immunocompetent patient.Infective endocarditis in the Lao PDR: clinical characteristics and outcomes in a developing countryManagement of neurological complications of infective endocarditis in ICU patientsInfective endocarditis in the Pacific: clinical characteristics, treatment and long-term outcomes.Strategies to enhance rational use of antibiotics in hospital: a guideline by the German Society for Infectious DiseasesValidated Risk Score for Predicting 6-Month Mortality in Infective Endocarditis.Heart transplantation as salvage therapy for progressive prosthetic valve endocarditis due to methicillin-resistant Staphylococcus epidermidis (MRSE).Lactobacillus reuteri and Escherichia coli in the human gut microbiota may predict weight gain associated with vancomycin treatmentAssociation between valvular surgery and mortality among patients with infective endocarditis complicated by heart failure.Infective endocarditis: therapeutic options and indications for surgery.Coronary Artery Fistula-Associated Endocarditis: Report of Two Cases and a Review of the Literature.From Expert Protocols to Standardized Management of Infectious Diseases.Pre-End-Stage Renal Disease Care and Early Survival among Incident Dialysis Patients in the US Military Health System.Evaluation of empirical treatment for blood culture-negative endocarditis.Infective endocarditis and multidisciplinary work: a call for action in Asia.Is brain angio-MRI useful in infective endocarditis management?[Infective endocarditis : Update on prophylaxis, diagnosis, and treatment].2015 ESC Guidelines for the management of infective endocarditis: The Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the EurMy paper 10 years later: infective endocarditis in the intensive care unit.Mechanism of outside-in {alpha}IIb{beta}3-mediated activation of human platelets by the colonizing Bacterium, Streptococcus gordoniiMaternal understanding of infective endocarditis after hospitalization: assessing the knowledge of mothers of children with congenital heart disease and the practical implications.Standards defining a 'Heart Valve Centre': ESC Working Group on Valvular Heart Disease and European Association for Cardiothoracic Surgery Viewpoint.2015 ESC Guidelines on the management of infective endocarditis: a big step forward for an old disease.Inception of the 'endocarditis team' is associated with improved survival in patients with infective endocarditis who are managed medically: findings from a before-and-after study.The infective endocarditis team: recommendations from an international working group.Long-term outcomes and cardiac surgery in critically ill patients with infective endocarditisStandards defining a ‘Heart Valve Centre’: ESC Working Group on Valvular Heart Disease and European Association for Cardiothoracic Surgery Viewpoint
P2860
Q28068781-D707C3CC-298D-4435-A6C5-D0F3366E35BCQ33531791-36D89868-8000-4369-9950-476240071865Q34433144-2DB815CA-F541-4BC2-8C87-62F3A60FEF79Q35068509-5253729D-70AA-4768-B956-371DB95FE8FEQ35574047-61E2EEC5-9E0B-4169-A4DF-F8C616E63FB6Q35578431-6AD5FD12-0281-4D1E-8D14-29372AC66248Q35986250-F3B79CD7-75BE-4868-91F2-83E273ADC0D5Q36877245-0AAA1C6E-71A2-4F39-ACCE-3D6A56A29804Q37081529-D210F0AE-D6F1-4DF8-992A-F2CC0536E5E4Q37211879-0CD0EB67-F3A5-44DC-A7C3-58E038D6D132Q37270240-AFCF9EE4-ABC0-41F6-A091-BDC06A2ED360Q38192511-0E7B7138-9B20-454A-986C-D1B83A37D9CBQ38582162-1BF67297-08C5-4EBF-84DB-2C65455EE15EQ38599614-18B5EC58-B917-431F-91D8-F031EE33A6AAQ38787516-7A387788-C3AD-489F-8034-BC20C78C5B8AQ38966426-4B377BE7-D14C-4E95-9A26-5522C3A1C5B3Q40222456-F7B78BAC-7A9B-40C8-BC23-226986C6A2BAQ40550225-82653E12-C63C-49CD-9DB5-8701BFA17EFBQ40679827-8DC46A5D-792B-45B4-B4E9-AB042BAFFBC3Q41026009-F8CE7776-B7A8-4FBF-A1FF-649E555F159CQ41732633-02BF3C7F-31D9-46CA-AFE7-76734517D061Q41885177-D9EB3ADE-6087-4537-AE9F-B2ED1CE85DDAQ45271193-2A76D529-6E84-42C0-8AE4-88E30583460EQ47681750-3838D3E2-BF8F-4FCB-A465-6F03066D788AQ47708454-F1A0313D-57B7-408B-B4C5-A0C06F5B8DDFQ49725453-C5F2E7DA-443F-4D2E-BC01-F6C6894DD9E8Q53104428-910C3351-282D-46AA-998A-0145EE528FF4Q57016668-070919E7-35C5-4023-AF92-F7DB53B30689Q57629463-025DC179-3C80-4D62-9237-A94F4A6EE4C0
P2860
Dramatic Reduction in Infective Endocarditis–Related Mortality With a Management-Based Approach
description
im Juli 2009 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована в липні 2009
@uk
name
Dramatic Reduction in Infectiv ...... th a Management-Based Approach
@en
Dramatic Reduction in Infectiv ...... th a Management-Based Approach
@nl
type
label
Dramatic Reduction in Infectiv ...... th a Management-Based Approach
@en
Dramatic Reduction in Infectiv ...... th a Management-Based Approach
@nl
prefLabel
Dramatic Reduction in Infectiv ...... th a Management-Based Approach
@en
Dramatic Reduction in Infectiv ...... th a Management-Based Approach
@nl
P2093
P1476
Dramatic Reduction in Infectiv ...... th a Management-Based Approach
@en
P2093
Alberto Riberi
Elisabeth Botelho-Nevers
Franck Thuny
Frédéric Collart
Frédérique Gouriet
Hervé Richet
Jean Paul Casalta
P356
10.1001/ARCHINTERNMED.2009.192
P407
P577
2009-07-27T00:00:00Z